P127 Rates of infection and bleeding are not increased in patients (Pts) with MDS treated with azacitidine (AZA) compared with best supportive care (BSC)

V. Santini, L. Silverman, J. Seymour, P. Fenaux, G. Mufti, E. Hellström-Lindberg, G. Sanz, C. Finelli, J. Backstom, D. McKenzie, C. Beach

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S133
JournalLeukemia Research
Issue numberSUPPL. 1
StatePublished - May 2009

Cite this